Beyond ''getting drugs into bodies'': Social science perspectives on pre-exposure prophylaxis for HIV

Journal of the International AIDS Society

Volumn 18, Issue , 2015, Pages

  Auerbach, Judith D ^a   Hoppe, Trevor A ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

HIV prevention; PrEP; Risk compensation; Sexuality; Social science

Indexed keywords

EMTRICITABINE PLUS TENOFOVIR DISOPROXIL; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

CONDOM USE; DRUG EFFICACY; EVIDENCE BASED PRACTICE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION CONTROL; INFECTION PREVENTION; MEN WHO HAVE SEX WITH MEN; PRE-EXPOSURE PROPHYLAXIS; PRIMARY PREVENTION; PRIORITY JOURNAL; REVIEW; SEXUAL BEHAVIOR; SEXUAL INTERCOURSE; SEXUAL PRACTICE; SEXUALITY; SOCIOLOGY; UNSAFE SEX; HIV INFECTIONS; MALE;

ANTI-HIV AGENTS; HIV INFECTIONS; HUMANS; MALE; PRE-EXPOSURE PROPHYLAXIS; SEXUAL BEHAVIOR; SOCIAL SCIENCES;

EID: 84938245608     PISSN: None     EISSN: 17582652     Source Type: Journal    
DOI: 10.7448/IAS.18.4.19983     Document Type: Review

References (42)

1. Grant RM, Lama JR, Anderson PL, McMahan V, Liu AY, Vargas L, et al. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med. 2010;363(27):2587-99.
2. Baeten JM, Donnell D, Ndase P, Mugo NR, Campbell JD, Wangisi J, et al. Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. N Engl J Med. 2012;367(5):399-410.
3. Thigpen MC, Kebaabetswe PM, Paxton LA, Smith DK, Rose CE, Segolodi TM, et al. Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana. N Engl J Med. 2012;367(5):423-34.
4. Choopanya K, Martin M, Suntharasamai P, Sangkum U, Mock PA, Leethochawalit M, et al. Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial. Lancet. 2013;381(9883): 2083-90.
5. Mansergh G, Koblin BA, Sullivan PS. Challenges for HIV pre-exposure prophylaxis among men who have sex with men in the United States. PLoS Med. 2012;9(8):e1001286.
6. Rosengarten M. Introduction: novel modes of inquiry to achieve effective HIV prevention. 20th International AIDS Conference; 2014 Jul 20-25; Melbourne, Australia.
7. Race K. Reluctant objects: sexual pleasure as a problem of HIV biomedical prevention. GLQ. Forthcoming.
8. Colbert C. CDC updates term for 'unprotected sex.' The Bay Area Reporter [Internet]. 2014 Feb [cited 2014 Dec 12]. Available from: http://ebar.com/news/article.php?sec-news&article-69482
9. Race K. The undetectable crisis: changing technologies of risk. Sexualities. 2001;4:167-89.
10. Hoppe T. Responsibilizing HIV-positive people through prevention: what are the implications? American Sociological Association Annual Meeting; 2014 Aug 16-19; San Francisco, CA.
11. AIDS Healthcare Foundation. No test? No pills: truvada for HIV preexposure prophylaxis (PrEP) is a safety risk [Internet]. No date [cited 2014 Dec 15]. Available from: http://www.nomagicpills.org
12. Van Damme L, Corneli A, Ahmed K, Agot K, Lombaard J, Kapiga S, et al. Preexposure prophylaxis for HIV infection among African women. N Engl J Med. 2012;367:411-22.
13. Molina JM, Capitant C, Charreau I, Meyer L, Spire B, Pialoux G, et al. On demand PrEP with oral TDF-FTC in MSM: results of the ANRS Ipergay Trial-23LB. Conference on Retroviruses and Opportunistic Infections; 2015 Feb 23-26; Seattle, WA.
14. Baeten JM, Heffron R. Pre-exposure prophylaxis to intensify the fight against HIV. Lancet Infect Dis. 2014;14(6):443-5.
15. McMahon JM, Myers JE, Kurth AE, Cohen SE, Mannheimer SB, Simmons J, et al. Oral pre-exposure prophylaxis (PrEP) for prevention of HIV in serodiscordant heterosexual couples in the United States: opportunities and challenges. AIDS Patient Care STDs. 2014;28(9):462-74.
16. Potts M. The urgent need for a vaginal microbicide in the prevention of HIV transmission. Am J Public Health. 1994;84(6):890-1.
17. Hilber AM, Chersich MF, Van de Wijgert JHHM, Rees H, Temmerman M. Vaginal practices, microbicides, and HIV: what do we need to know? Sex Transm Infect. 2007;83(7):505-7.
18. Philbin MM, Parker R, Wilson P, Grisham K, Parker C, Garcia J, et al. How Black men who have sex with men in New York city understand, talk about, and experience pre-exposure prophylaxis (PrEP). MOPE293. 20th International AIDS Conference; 2014 Jul 20-25; Melbourne, Australia.
19. AVAC. 2013 research & reality. AVAC report [Internet]. New York, NY: AVAC; 2013 Dec [cited 2014 Dec 15]. Available from: http://www.avac.org/sites/default/files/resource-files/AVAC Report 2013-0.pdf
20. Auerbach JD, Kinsky S, Brown G, Charles V. Knowledge, attitudes, and likelihood of pre-exposure prophylaxis (PrEP) use among US women at risk of acquiring HIV. AIDS Patient Care STDs. 2015;29(2):102-10.
21. van der Straten A, Stadler J, Luecke E, Laborde N, Hartmann M, Montgomery ET, et al. Perspectives on use of oral and vaginal antiretrovirals for HIV prevention: the VOICE-C qualitative study in Johannesburg, South Africa. J Int AIDS Soc. 2014;17(Suppl 2):19146, doi: http://dx.doi.org/10.7448/IAS.17.3.19146
22. Smith DK, Herbst JH, Zhang X, Rose CE. Condom effectiveness for HIV prevention by consistency of use among men who have sex with men (MSM) in the U.S. J Acquir Immune Defic Syndr. 2015;68(3):337-44.
23. Marcus JL, Glidden DV, Mayer KH, Liu AY, Buchbinder SP, Amico KR, et al. No evidence of sexual risk compensation in the iPrEx trial of daily oral HIV preexposure prophylaxis. PLoS One. 2013;8(12):e81997.
24. Grant RM, Anderson PL, McMahan V, Liu A, Amico KR, Mehrotra M, et al. Uptake of pre-exposure prophylaxis, sexual practices, and HIV incidence in men and transgender women who have sex with men: a cohort study. Lancet Infect Dis. 2014;14(9):820-9.
25. Mugwanya KK, Donnell D, Celum C, Thomas KK, Ndase P, Mugo N, et al. Sexual behaviour of heterosexual men and women receiving antiretroviral preexposure prophylaxis for HIV prevention: a longitudinal analysis. Lancet Infect Dis. 2013;13(12):1021-8.
26. Duran D. Truvada whores? Huffington Post [Internet]. 2012 Nov [cited 2014 Oct 30]. Available from: http://www.huffingtonpost.com/david-duran/truvada-whores-b-2113588.html
27. Sobo, J. Does taking PrEP make me a whore? Positive Frontiers [Internet]. 2012 Nov [cited 2014 Oct 30]. Available from: http://www.frontiersla.com/mylifeonprep/story.aspx?ID-1829620
28. An Z, McLaughlin M, Hou J, Nam Y, Hu C, Park M, et al. Social network representation and dissemination of pre-pxposure prophylaxis (PrEP): a semantic network analysis of HIV prevention drug on Twitter. Soc Comput Soc Media. 2014;8531:160-9.
29. Villarreal D. HIV testing counselor sells 'Truvada whore' shirts for AIDS charity. Towleroad [Internet]. 2014 Mar [cited 2014 Oct 30]. Available from: http://www.towleroad.com/2014/03/hiv-testing-counselor-sells-truvada-whoreshirts-for-aids-charity.html
30. Myers JE, Sepkowitz KA. A pill for HIV prevention: dé javu all over again? Clin Infect Dis. 2013;56(11):1604-12.
31. Venter F, Allais L, Richter M. Exposure ethics: does HIV pre-exposure prophylaxis raise ethical problems for the health care provider and policy maker? Bioethics. 2014;28(6):269-74.
32. Barucco R. Beyond ''poz'' and ''neg'': five HIV statuses, plus a new one. Huffington Post [Internet]. 2014 Mar [cited 2014 Oct 29]. Available from: http://www.huffingtonpost.com/renato-barucco/beyond-poz-and-neg-five-h-b-5039729.html
33. Sullivan A. Is the HIV divide now over? The Dish [Internet]. 2014 Sept [cited 2014 Oct 29]. Available from: http://dish.andrewsullivan.com/2014/09/30/is-the-hiv-divide-now-over/
34. Sobo J. Choosing to love poz guys. BETA Blog [Internet]. 2014 Sept [cited 2014 Oct 29]. Available from: http://betablog.org/choosing-love-poz-guys/
35. Benjamin R. PrEP and prejudice. POZ Magazine [Internet]. 2014 Oct [cited 2014 Oct 29]. Available from: http://www.poz.com/articles/prep-prejudice-2881-26226.shtml
36. Ware NC,Wyatt MA, Haberer JE, Baeten JM, Kintu A, Psaros C, et al. What's love got to do with it? Explaining adherence to oral antiretroviral pre-exposure prophylaxis (PrEP) for HIV serodiscordant couples. J Acquir Immune Defic Syndr. 2012;59(5):463-8.
37. Lampe MA, Smith DK, Anderson GJE, Edwards AE, Nesheim SR. Achieving safe conception in HIV-discordant couples: the potential role of oral preexposure prophylaxis (PrEP) in the United States. Am J Obstet Gynecol. 2011;204(6):488.1-8.
38. Baggely R. Presentation at NEMUS affiliated event. 20th International AIDS Conference; 2014 July 20-25; Melbourne, Australia.
39. Curran JW, Crosby RA. Pre-exposure prophylaxis for HIV: who will benefit and what are the challenges? Am J Prev Med. 2013;44(1 Suppl 2):S163-6.
40. Rennie S. Ethical use of antiretroviral resources for HIV prevention in resource poor settings. Dev World Bioeth. 2013;13(2):79-86.
41. Galindo GR, Walker JJ, Hazelton P, Lane T, Steward WT, Morin SF, et al. Community member perspectives from transgender women and men who have sex with men on pre-exposure prophylaxis as an HIV prevention strategy: implications for implementation. Implement Sci. 2012;7:116.
42. Aggleton P. Social research and the response to HIV: legacy and future. CSRH-ARCSHS AIDS 2014 Symposium; 2014 Jul 18; Melbourne, Australia.